On July 22, 2025, Spruce Biosciences, Inc. stockholders approved a one-for-seventy-five reverse stock split, effective August 4, 2025, with stock trading starting on August 5, 2025. They also elected two directors and ratified their independent accounting firm for fiscal 2025.